Found: 144
Select item for more details and to access through your institution.
Prognostic Factor Analysis in Patients With Small-Cell Lung Cancer Treated With Third-Line Chemotherapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 232, doi. 10.1007/s10637-020-00966-7
- By:
- Publication type:
- Article
Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome‐wide association and whole genome sequencing analyses.
- Published in:
- Cancer Communications, 2024, v. 44, n. 2, p. 287, doi. 10.1002/cac2.12498
- By:
- Publication type:
- Article
Large pulmonary sclerosing pneumocytoma with massive necrosis and vascular invasion: a case report.
- Published in:
- Oxford Medical Case Reports, 2019, v. 2019, n. 7, p. N.PAG, doi. 10.1093/omcr/omz066
- By:
- Publication type:
- Article
Clinical Indicators to Guide Reoperation for Postoperative Hemorrhage After Pulmonary Resection for Malignancy: A Single-Institutional Experience of 22 Cases.
- Published in:
- Open Access Surgery, 2024, v. 17, p. 95, doi. 10.2147/OAS.S459703
- By:
- Publication type:
- Article
Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort study.
- Published in:
- BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02749-1
- By:
- Publication type:
- Article
Utility of bronchoscopically obtained frozen cytology pellets for next-generation sequencing.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12250-5
- By:
- Publication type:
- Article
Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes.
- Published in:
- Carcinogenesis, 2010, v. 31, n. 5, p. 834, doi. 10.1093/carcin/bgq003
- By:
- Publication type:
- Article
Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese.
- Published in:
- Carcinogenesis, 2009, v. 30, n. 1, p. 65, doi. 10.1093/carcin/bgn257
- By:
- Publication type:
- Article
A secondary RET mutation in the activation loop conferring resistance to vandetanib.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-02994-7
- By:
- Publication type:
- Article
Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.
- Published in:
- Nature Communications, 2016, v. 7, n. 8, p. 12451, doi. 10.1038/ncomms12451
- By:
- Publication type:
- Article
Successful Treatment with Crizotinib to Overcome Drug Resistance Possibly Due to Mesenchymal-epithelial Transition Amplification in a Lung Cancer Patient with the Echinoderm Microtubule-associated Protein-like 4-anaplastic Lymphoma Kinase Fusion Gene.
- Published in:
- Internal Medicine, 2023, v. 62, n. 21, p. 3215, doi. 10.2169/internalmedicine.1164-22
- By:
- Publication type:
- Article
Comparative evaluation of the Desoxycholate Agar Nissui Food Stamp and swab methods for estimating coliform organisms in poultry processing plants after cleaning in Japan.
- Published in:
- Journal of Basic Microbiology, 2004, v. 44, n. 6, p. 445
- By:
- Publication type:
- Article
Prognostic impact of EGFR/ALK alterations in leptomeningeal metastasis from lung adenocarcinoma treated with whole-brain radiotherapy.
- Published in:
- Clinical & Experimental Metastasis, 2023, v. 40, n. 5, p. 407, doi. 10.1007/s10585-023-10225-7
- By:
- Publication type:
- Article
Successful Everolimus Treatment in a Patient with Advanced Pancreatic Neuroendocrine Tumor Who Developed Everolimus-Induced Interstitial Lung Disease on Two Occasions: A Case Report.
- Published in:
- Chemotherapy (0009-3157), 2013, v. 59, n. 1, p. 74, doi. 10.1159/000351103
- By:
- Publication type:
- Article
A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population.
- Published in:
- Nature Genetics, 2012, v. 44, n. 8, p. 900, doi. 10.1038/ng.2353
- By:
- Publication type:
- Article
Detection of Early Invasion on the Basis of Basement Membrane Destruction in Small Adenocarcinomas of the Lung and Its Clinical Implications.
- Published in:
- Modern Pathology, 2001, v. 14, n. 12, p. 1237, doi. 10.1038/modpathol.3880468
- By:
- Publication type:
- Article
Clinicopathologic and DNA Cytometric Analysis of Carcinoid Tumors of the Thymus.
- Published in:
- Modern Pathology, 2001, v. 14, n. 10, p. 985, doi. 10.1038/modpathol.3880423
- By:
- Publication type:
- Article
Isolation and Identification of Sodium 2-Propenyl Thiosulfate from Boiled Garlic (Allium sativum) That Oxidizes Canine Erythrocytes.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2003, v. 67, n. 7, p. 1594, doi. 10.1271/bbb.67.1594
- By:
- Publication type:
- Article
Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 52, n. 1, p. 19, doi. 10.1007/s00280-003-0618-8
- By:
- Publication type:
- Article
Long-term survival after complete resection of non-small-cell lung cancer in patients with interstitial lung disease.
- Published in:
- Interactive Cardiovascular & Thoracic Surgery, 2018, v. 26, n. 4, p. 638, doi. 10.1093/icvts/ivx400
- By:
- Publication type:
- Article
The prognostic impact of a high number of peritumoral alveolar macrophages in neuroendocrine carcinoma in the lung.
- Published in:
- Pathology International, 2023, v. 73, n. 10, p. 497, doi. 10.1111/pin.13365
- By:
- Publication type:
- Article
Phase II, open-label, multicenter trial of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Long-term survival outcome after postoperative recurrence of non-small- cell lung cancer: who is 'cured' from postoperative recurrence?
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2017, v. 52, n. 3, p. 522, doi. 10.1093/ejcts/ezx127
- By:
- Publication type:
- Article
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1142, doi. 10.1007/s10147-024-02543-x
- By:
- Publication type:
- Article
Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1828, doi. 10.1007/s10147-022-02232-7
- By:
- Publication type:
- Article
Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 5, p. 485, doi. 10.1007/s10147-019-01396-z
- By:
- Publication type:
- Article
Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 1, p. 70, doi. 10.1007/s10147-016-1039-0
- By:
- Publication type:
- Article
Erratum to: Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Correction to: Tumor size exceeding 5 cm as a valid prognostic factor in all stages of thymic epithelial tumors.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Tumor size exceeding 5 cm as a valid prognostic factor in all stages of thymic epithelial tumors.
- Published in:
- Surgery Today, 2023, v. 53, n. 1, p. 42, doi. 10.1007/s00595-022-02530-7
- By:
- Publication type:
- Article
Correction to: Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 4, p. 1227, doi. 10.1007/s00432-020-03413-5
- By:
- Publication type:
- Article
Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 10, p. 2495, doi. 10.1007/s00432-019-03012-z
- By:
- Publication type:
- Article
Podoplanin-positive cancer-associated fibroblast recruitment within cancer stroma is associated with a higher number of single nucleotide variants in cancer cells in lung adenocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 5, p. 893, doi. 10.1007/s00432-018-2619-3
- By:
- Publication type:
- Article
Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastases.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 6, p. 1075, doi. 10.1007/s00432-017-2350-5
- By:
- Publication type:
- Article
Genetic Profiling of Non‐Small Cell Lung Cancer at Development of Resistance to First‐ or Second‐Generation EGFR‐TKIs by CAPP‐Seq Analysis of Circulating Tumor DNA.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. 1022, doi. 10.1634/theoncologist.2019-0101
- By:
- Publication type:
- Article
Impressive response to nivolumab of non‐small‐cell lung cancer containing sarcomatoid components.
- Published in:
- Respirology Case Reports, 2019, v. 7, n. 8, p. N.PAG, doi. 10.1002/rcr2.477
- By:
- Publication type:
- Article
Response to Crizotinib Re-administration After Progression on Lorlatinib in a Patient With ALK-rearranged Non-small-cell Lung Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of EGFR Mutation and ALK Translocation on Recurrence Pattern After Definitive Chemoradiotherapy for Inoperable Stage III Non-squamous Non-small-cell Lung Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Chemoradiotherapy in Elderly Patients With Non-Small-Cell Lung Cancer: Long-Term Follow-Up of a Randomized Trial (JCOG0301).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Impact of Gastric Acid-Suppressing Medication Use on the Efficacy of Erlotinib and Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinical Impact of Gastric Acid-Suppressing Medication Use on the Efficacy of Erlotinib and Gefitinib in Patients With Advanced Non—Small-Cell Lung Cancer Harboring EGFR Mutations.
- Published in:
- Clinical Lung Cancer, 2016, v. 17, n. 5, p. 412, doi. 10.1016/j.cllc.2016.01.006
- By:
- Publication type:
- Article
Three‐year follow‐up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non‐small cell lung cancer: Pooled analysis of ONO‐4538‐05 and ONO‐4538‐06 studies.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 11, p. 5183, doi. 10.1002/cam4.2411
- By:
- Publication type:
- Article
Multiplex gene‐panel testing for lung cancer patients.
- Published in:
- Pathology International, 2020, v. 70, n. 12, p. 921, doi. 10.1111/pin.13023
- By:
- Publication type:
- Article
Secretion of high amounts of hepatocyte growth factor is a characteristic feature of cancer‐associated fibroblasts with EGFR‐TKI resistance‐promoting phenotype: A study of 18 cases of cancer‐associated fibroblasts.
- Published in:
- Pathology International, 2019, v. 69, n. 8, p. 472, doi. 10.1111/pin.12838
- By:
- Publication type:
- Article
Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: Identification of prognostic microenvironmental factors after chemoradiation.
- Published in:
- Pathology International, 2013, v. 63, n. 12, p. 599, doi. 10.1111/pin.12122
- By:
- Publication type:
- Article
Clinicopathological characteristics of EGFR mutated adenosquamous carcinoma of the lung.
- Published in:
- Pathology International, 2013, v. 63, n. 2, p. 77, doi. 10.1111/pin.12033
- By:
- Publication type:
- Article